Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Reiss KA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal for Equity in Health, Vol 9, Iss 1, p 15 (2010)
Abstract Background It can be assumed that resettlers (ethnic German immigrants from the Former Soviet Union) show similar smoking patterns as persons in their countries of origin at the time of migration. We analysed how the smoking prevalence among
Externí odkaz:
https://doaj.org/article/19ff8ace7f1148fe84ba465d9be3ca3e
Autor:
Steubesand Nadine, Kiehne Karlheinz, Brunke Gabriele, Pahl Rene, Reiss Karina, Herzig Karl-Heinz, Schubert Sabine, Schreiber Stefan, Fölsch Ulrich R, Rosenstiel Philip, Arlt Alexander
Publikováno v:
BMC Immunology, Vol 10, Iss 1, p 36 (2009)
Abstract Background Candida albicans resides on epithelial surfaces as part of the physiological microflora. However, under certain conditions it may cause life-threatening infections like Candida sepsis. Human β-defensins (hBDs) are critical compon
Externí odkaz:
https://doaj.org/article/c4373ae6c2c04a1ca85c29cb19533cd3
Publikováno v:
Molecular Neurodegeneration, Vol 4, Iss 1, p 17 (2009)
Abstract Background The low-density lipoprotein receptor-related protein 1 (LRP1) plays critical roles in lipid metabolism, cell survival, and the clearance of amyloid-β (Aβ) peptide. Functional soluble LRP1 (sLRP1) has been detected in circulating
Externí odkaz:
https://doaj.org/article/434041a45c074019b66363a2f07843ae
Autor:
Han X; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA., Burrows M; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA., Kim LC; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA., Xu JP; Centers for Cancer Pharmacology and Excellence in Environmental Toxicology, Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA., Vostrejs W; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA., Van Le TN; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Poltorack C; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA., Jiang Y; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA., Cukierman E; Cancer Signaling & Microenvironment Program, Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Temple Health, Philadelphia, PA 19111, USA., Stanger BZ; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Reiss KA; Division of Hematology-Oncology, Penn Medicine Abramson Cancer Center, Philadelphia, PA 19104, USA., Shaffer SM; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Mesaros C; Centers for Cancer Pharmacology and Excellence in Environmental Toxicology, Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA., Keith B; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA., Simon MC; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: celeste2@pennmedicine.upenn.edu.
Publikováno v:
Cell reports [Cell Rep] 2024 Nov 12; Vol. 43 (11), pp. 114972. Date of Electronic Publication: 2024 Nov 12.
Autor:
Than MT; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., O'Hara M; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Stanger BZ; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Reiss KA; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Oct 01; Vol. 23 (10), pp. 1378-1388.
Autor:
Lau-Min KS; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Symecko H; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Spielman K; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Mann D; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hood R; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Rathore S; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Wolfe C; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Gabriel PE; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Rendle KA; Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Nathanson KL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Reiss KA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Domchek SM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jul 18, pp. OP2400356. Date of Electronic Publication: 2024 Jul 18.
Autor:
Till JE; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., McDaniel L; Personalis, Inc., Menlo Park, CA, USA., Chang C; Indiana University School of Medicine, Indianapolis, IN, USA., Long Q; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Da Silva DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Abbott C; Personalis, Inc., Menlo Park, CA, USA., Chen RO; Personalis, Inc., Menlo Park, CA, USA., Boyle SM; Personalis, Inc., Menlo Park, CA, USA., Bhagwat N; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Cannas S; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Sagreiya H; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Li W; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Yee SS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Abdalla A; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Wang Z; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Yin M; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Ballinger D; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Wissel P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Eads J; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Karasic T; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Schneider C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., O'Dwyer P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Teitelbaum U; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Reiss KA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Rahma OE; Dana-Farber Cancer Institute, Boston, MA, USA., Fisher GA; Stanford University, Stanford, CA, USA., Ko AH; University of California, San Francisco, San Francisco, CA, USA., Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA., Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA., Carpenter EL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. erical@upenn.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 09; Vol. 15 (1), pp. 5763. Date of Electronic Publication: 2024 Jul 09.
Autor:
Anbil S; Abramson Cancer Center, 10th Floor Perelman Center South, The University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA, 19121, USA., Reiss KA; Abramson Cancer Center, 10th Floor Perelman Center South, The University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA, 19121, USA. Kim.ReissBinder@Pennmedicine.upenn.edu.
Publikováno v:
Current treatment options in oncology [Curr Treat Options Oncol] 2024 Mar; Vol. 25 (3), pp. 346-363. Date of Electronic Publication: 2024 Jan 04.
Autor:
Brown TJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, Pennsylvania., Yablonovitch A; Guardant Health, Redwood City, California., Till JE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Yen J; Guardant Health, Redwood City, California., Kiedrowski LA; Guardant Health, Redwood City, California., Hood R; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., O'Hara MH; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Teitelbaum U; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Karasic TB; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Schneider C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Carpenter EL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Nathanson K; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Domchek SM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Reiss KA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 15; Vol. 29 (24), pp. 5207-5216.